Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Progress in the use of biological therapies to treat paroxysmal nocturnal hemoglobinuria: focus on patient profiling.
Journal: Expert opinion on biological therapy
Published: October 13, 2025
Challenges in optimizing targeted complement inhibitor therapy for paroxysmal nocturnal hemoglobinuria in an expanding treatment landscape
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Successful switch from pegcetacoplan to iptacopan after repeated severe breakthrough hemolysis events - case report.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 20, 2025
New treatment strategies for paroxysmal nocturnal hemoglobinuria: drug selection in the era of novel complement inhibitors
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 03, 2025
Neuromuscular junction and the complement system.
Journal: International review of neurobiology
Published: July 17, 2025
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience.
Journal: American journal of hematology
Published: July 17, 2025
Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors.
Journal: Science advances
Published: July 09, 2025
Pharmacological characteristics and clinical study results of danicopan (Voydeya® tablets)
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: July 02, 2025
Dual therapy: danicopan as add-on therapy to C5 inhibitors.
Journal: Clinical advances in hematology & oncology : H&O
Published: July 01, 2025
Navigating the paroxysmal nocturnal hemoglobinuria (PNH) landscape.
Journal: Clinical advances in hematology & oncology : H&O
Published: July 01, 2025
Danicopan: complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria.
Journal: Trends in pharmacological sciences
Published: June 25, 2025
Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment.
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: April 21, 2025
Last Updated: 10/31/2025